Sandbox 1666

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Current revision (22:35, 18 April 2021) (edit) (undo)
 
(4 intermediate revisions not shown.)
Line 22: Line 22:
<scene name='88/880343/Space_filling_view/1'>Here</scene> is a space fill of CTX-M Beta-Lactamase, which shows where the interactions are in between each domain and where the active sites are located.
<scene name='88/880343/Space_filling_view/1'>Here</scene> is a space fill of CTX-M Beta-Lactamase, which shows where the interactions are in between each domain and where the active sites are located.
-
<scene name='88/880343/Hydrophobicity_view/1'>Here</scene> is a view of hydrophobic interactions that are within domain A of the enzyme.
+
<scene name='88/880343/Hydrophobic-polar_view/2'>Here</scene> is a view of hydrophobic/polar interactions that are within domain A of the enzyme.
== Other Important Features ==
== Other Important Features ==
Line 29: Line 29:
== References ==
== References ==
-
<references/>
+
Soeung V, Lu S, Hu L, Judge A, Sankaran B, Prasad BVV, Palzkill T. A drug-resistant β-lactamase variant changes the conformation of its active-site proton shuttle to alter substrate specificity and inhibitor potency. J Biol Chem. 2020 Dec 25;295(52):18239-18255. doi: 10.1074/jbc.RA120.016103. Epub 2020 Oct 26. PMID: 33109613.

Current revision

CTX-M Beta-Lactamase

CTX-M Beta Lactamase is a class a enzyme. This enzyme creates drug resistance to ampicillin and cefotaxime through a two step process: deacylation and acylation.

Escherichia coli reca protein-bound DNA (PDB entry 3rec)

Drag the structure with the mouse to rotate

References

Soeung V, Lu S, Hu L, Judge A, Sankaran B, Prasad BVV, Palzkill T. A drug-resistant β-lactamase variant changes the conformation of its active-site proton shuttle to alter substrate specificity and inhibitor potency. J Biol Chem. 2020 Dec 25;295(52):18239-18255. doi: 10.1074/jbc.RA120.016103. Epub 2020 Oct 26. PMID: 33109613.

Personal tools